(+)-Arisugacin A——乙酰胆碱酯酶双重结合位点共价抑制剂的计算证据。
(+)-Arisugacin A--computational evidence of a dual binding site covalent inhibitor of acetylcholinesterase.
机构信息
Alchemical Research, LLC, 426 Heckewelder Place, Bethlehem, PA 18018, USA.
出版信息
Bioorg Med Chem Lett. 2011 May 1;21(9):2687-91. doi: 10.1016/j.bmcl.2010.12.041. Epub 2010 Dec 16.
Abstract
A computation docking study of the highly potent, non-nitrogen containing, acetylcholinesterase inhibitor (+)-arisugacin A is presented. The model suggests that (+)-arisugacin A is a dual binding site covalent inhibitor of AChE. These findings are examined in the context of Alzheimer's disease-modifying therapeutic design. (+)-Arisugacin A's revealed mode of action is unique, and may serve as a basis for the development of AD therapeutics capable of treating the symptomatic aspects of AD, while being neuroprotective with long term efficacy.
摘要
呈现了一种高效能、非含氮、乙酰胆碱酯酶抑制剂 (+)-阿里他汀 A 的计算对接研究。该模型表明，(+)-阿里他汀 A 是 AChE 的双结合位点共价抑制剂。这些发现是在阿尔茨海默病治疗设计的背景下进行检查的。(+)-阿里他汀 A 的作用机制是独特的，可能成为开发能够治疗 AD 症状的 AD 治疗药物的基础，同时具有长期疗效的神经保护作用。
相似文献
1
(+)-Arisugacin A--computational evidence of a dual binding site covalent inhibitor of acetylcholinesterase.(+)-Arisugacin A——乙酰胆碱酯酶双重结合位点共价抑制剂的计算证据。
Bioorg Med Chem Lett. 2011 May 1;21(9):2687-91. doi: 10.1016/j.bmcl.2010.12.041. Epub 2010 Dec 16.
2
A computational view on the significance of E-ring in binding of (+)-arisugacin A to acetylcholinesterase.关于E环在(+)-阿里苏加辛A与乙酰胆碱酯酶结合中重要性的计算观点。
Bioorg Med Chem Lett. 2015 Nov 1;25(21):4848-4853. doi: 10.1016/j.bmcl.2015.06.047. Epub 2015 Jun 27.
3
Highly functionalized 2-amino-4H-pyrans as potent cholinesterase inhibitors.高官能化的 2-氨基-4H-吡喃作为强效的胆碱酯酶抑制剂。
Bioorg Chem. 2018 Dec;81:134-143. doi: 10.1016/j.bioorg.2018.08.009. Epub 2018 Aug 12.
4
Convergent synthesis of arisugacin skeletons and their acetylcholinesterase inhibitory activity.阿瑞苏加辛骨架的汇聚合成及其乙酰胆碱酯酶抑制活性。
J Antibiot (Tokyo). 2001 Apr;54(4):382-5. doi: 10.7164/antibiotics.54.382.
5
The first total synthesis of (+/-)-arisugacin A, a potent, orally bioavailable inhibitor of acetylcholinesterase.（±）-阿里苏加辛A的首次全合成，一种强效的、口服生物可利用的乙酰胆碱酯酶抑制剂。
Org Lett. 2002 Feb 7;4(3):367-9. doi: 10.1021/ol017046x.
6
Arisugacins, selective acetylcholinesterase inhibitors of microbial origin.阿里苏加菌素，微生物来源的选择性乙酰胆碱酯酶抑制剂。
Pharmacol Ther. 1997 Oct-Dec;76(1-3):45-54. doi: 10.1016/s0163-7258(97)00093-4.
7
Synthesis of dihydroxanthone derivatives and evaluation of their inhibitory activity against acetylcholinesterase: unique structural analogs of tacrine based on the BCD-ring of arisugacin.二氢氧杂蒽酮衍生物的合成及其对乙酰胆碱酯酶抑制活性的评价：基于阿里苏加辛BCD环的他克林独特结构类似物。
Bioorg Med Chem Lett. 1999 Apr 5;9(7):973-8. doi: 10.1016/s0960-894x(99)00115-8.
8
Structural determinants of the multifunctional profile of dual binding site acetylcholinesterase inhibitors as anti-Alzheimer agents.双结合位点乙酰胆碱酯酶抑制剂作为抗阿尔茨海默病药物的多功能特性的结构决定因素。
Curr Pharm Des. 2010;16(25):2818-36. doi: 10.2174/138161210793176536.
9
Design and synthesis of dual inhibitors of acetylcholinesterase and serotonin transporter targeting potential agents for Alzheimer's disease.针对阿尔茨海默病潜在药物的乙酰胆碱酯酶和5-羟色胺转运体双重抑制剂的设计与合成
Org Lett. 2002 Oct 3;4(20):3359-62. doi: 10.1021/ol026418e.
10
From dual binding site acetylcholinesterase inhibitors to allosteric modulators: A new avenue for disease-modifying drugs in Alzheimer's disease.从双结合位点乙酰胆碱酯酶抑制剂到变构调节剂：阿尔茨海默病疾病修饰药物的新途径。
Eur J Med Chem. 2017 Oct 20;139:773-791. doi: 10.1016/j.ejmech.2017.08.051. Epub 2017 Aug 26.
引用本文的文献
1
A computational view on the significance of E-ring in binding of (+)-arisugacin A to acetylcholinesterase.关于E环在(+)-阿里苏加辛A与乙酰胆碱酯酶结合中重要性的计算观点。
Bioorg Med Chem Lett. 2015 Nov 1;25(21):4848-4853. doi: 10.1016/j.bmcl.2015.06.047. Epub 2015 Jun 27.
2
Territrem and butyrolactone derivatives from a marine-derived fungus Aspergillus terreus.来源于海洋真菌土曲霉的震颤素和丁内酯衍生物。
Mar Drugs. 2014 Dec 17;12(12):6113-24. doi: 10.3390/md12126113.
3
Structures of human acetylcholinesterase bound to dihydrotanshinone I and territrem B show peripheral site flexibility.与二氢丹参酮I和震颤毒素B结合的人乙酰胆碱酯酶结构显示出外周位点的灵活性。
ACS Med Chem Lett. 2013 Sep 23;4(11):1091-6. doi: 10.1021/ml400304w. eCollection 2013 Nov 14.
4
Nature: a substantial source of auspicious substances with acetylcholinesterase inhibitory action.天然产物：具有乙酰胆碱酯酶抑制作用的吉祥物质的重要来源。
Curr Neuropharmacol. 2013 Jul;11(4):379-87. doi: 10.2174/1570159X11311040003.
5
Natural products as a rich source of tau-targeting drugs for Alzheimer's disease.天然产物是阿尔茨海默病tau 靶向药物的丰富来源。
Future Med Chem. 2012 Sep;4(13):1751-61. doi: 10.4155/fmc.12.124.
本文引用的文献
1
A Concise Stereoselective Route to the Pentacyclic Frameworks of Arisugacin A and Territrem B.一条通往阿瑞苏加辛A和地曲霉素B五环骨架的简洁立体选择性合成路线。
Angew Chem Int Ed Engl. 2000 Nov 3;39(21):3876-3879. doi: 10.1002/1521-3773(20001103)39:21<3876::AID-ANIE3876>3.0.CO;2-C.
2
Selective acetylcholinesterase inhibitor activated by acetylcholinesterase releases an active chelator with neurorescuing and anti-amyloid activities.乙酰胆碱酯酶激活的选择性乙酰胆碱酯酶抑制剂释放具有神经保护和抗淀粉样活性的有效螯合剂。
ACS Chem Neurosci. 2010 Nov 17;1(11):737-46. doi: 10.1021/cn100069c. Epub 2010 Oct 4.
3
Aza-[3 + 3] Annulations: A New Unified Strategy in Alkaloid Synthesis.氮杂-[3 + 3]环合反应：生物碱合成中的一种新的统一策略。
Curr Org Synth. 2010 Aug 1;7(4):363-401. doi: 10.2174/157017910791414490.
4
Site-activated chelators targeting acetylcholinesterase and monoamine oxidase for Alzheimer's therapy.针对阿尔茨海默病治疗的靶向乙酰胆碱酯酶和单胺氧化酶的位点激活螯合剂。
ACS Chem Biol. 2010 Jun 18;5(6):603-10. doi: 10.1021/cb900264w.
5
Effects of cholinesterase inhibitors on the activities and protein levels of cholinesterases in the cerebrospinal fluid of patients with Alzheimer's disease: a review of recent clinical studies.胆碱酯酶抑制剂对阿尔茨海默病患者脑脊液中胆碱酯酶活性和蛋白水平的影响：对近期临床研究的综述。
Curr Alzheimer Res. 2010 Feb;7(1):67-73. doi: 10.2174/156720510790274455.
6
Pyrano[3,2-c]quinoline-6-chlorotacrine hybrids as a novel family of acetylcholinesterase- and beta-amyloid-directed anti-Alzheimer compounds.吡喃并[3,2-c]喹啉-6-氯他克林杂合物作为一类新型的乙酰胆碱酯酶和β-淀粉样蛋白导向的抗阿尔茨海默病化合物。
J Med Chem. 2009 Sep 10;52(17):5365-79. doi: 10.1021/jm900859q.
7
AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading.AutoDock Vina：通过新的评分函数、高效优化和多线程改进对接的速度和准确性。
J Comput Chem. 2010 Jan 30;31(2):455-61. doi: 10.1002/jcc.21334.
8
Site-activated multifunctional chelator with acetylcholinesterase and neuroprotective-neurorestorative moieties for Alzheimer's therapy.用于阿尔茨海默病治疗的具有乙酰胆碱酯酶和神经保护 - 神经修复部分的位点激活多功能螯合剂。
J Med Chem. 2009 Jul 23;52(14):4095-8. doi: 10.1021/jm900504c.
9
Different cholinesterase inhibitor effects on CSF cholinesterases in Alzheimer patients.不同胆碱酯酶抑制剂对阿尔茨海默病患者脑脊液胆碱酯酶的影响。
Curr Alzheimer Res. 2009 Feb;6(1):4-14. doi: 10.2174/156720509787313961.
10
Design, synthesis and biological evaluation of novel dual inhibitors of acetylcholinesterase and beta-secretase.新型乙酰胆碱酯酶和β-分泌酶双重抑制剂的设计、合成及生物学评价
Bioorg Med Chem. 2009 Feb 15;17(4):1600-13. doi: 10.1016/j.bmc.2008.12.067. Epub 2009 Jan 6.
Zotero 插件